Didn’t see anything about expected out going costs for covid19 trial. Would have been interesting to see a forecast of expected cost to get an idea of financial position should current phase 2 trials not be successful.
Ann: Quarterly Appendix 4C and Activities Report, page-6
-
- There are more pages in this discussion • 213 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
-0.035(7.22%) |
Mkt cap ! $247.5M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 48.5¢ | 44.5¢ | $1.897M | 4.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 79166 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 103477 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |